Nurix Therapeutics, Inc. (NRIX) stock
NRIXNasdaqPharmaceutical PreparationsFiscal year ends November 30
Financials through Q3 FY2026, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 13, 2026Score 15/3073% below fair value
$15.48−0.12 (-0.77%)
Close on Nov 13, 2026Market cap $1.69BP/E 6.7Yield 0.00%
Nurix Therapeutics statistics
89 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Jan 27, 2027 (estimated, after the close)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Aug 31, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 1.75
- 2.22
- P/OCF Ratio
- 4.46
- 12.99
Enterprise valuationIndustry
- EV / Sales
- 0.84
- 2.57
- EV / EBIT
- 2.04
- 19.31
- EV / FCF
- 1.60
- 22.27
Share statisticsIndustry
- Shares Change (YoY)
- 31.0%
- 10.8%
- Shares Change (QoQ)
- 5.30%
- 0.50%
- Float
- 106M
- 49M
- Shares Held by Insiders
- 3.19%
- 11.7%
- Shares Held by Institutions
- 107.4%
- 56.4%
Short sellingIndustry
- Short Interest
- 19M
- –
- Short Interest Change
- -8.11%
- -0.80%
- Short % of Float
- 17.9%
- 9.01%
- Short % of Shares Outstanding
- 17.3%
- 6.30%
- Days to Cover
- 7.17
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $28.23
- –
- 52-Week Low
- $12.01
- –
- 20-Day Moving Average
- $21.92
- –
- 50-Day Moving Average
- $23.27
- –
- 200-Day Moving Average
- $20.13
- –
- Average True Range (14)
- $1.54
- –
- Price Change (1 Week)
- 1.18%
- -1.15%
- Price Change (1 Month)
- -38.0%
- -4.87%
- Price Change (3 Months)
- -43.0%
- -21.0%
- Price Change (6 Months)
- -2.37%
- -20.6%
- Price Change (YTD)
- -18.4%
- -23.6%
- Price Change (1 Year)
- 27.2%
- -22.4%
- Price Change (3 Years)
- 145.7%
- -29.5%
- Price Change (5 Years)
- -54.6%
- -77.9%
- Average Volume (10 Days)
- 5M
- –
- Average Volume (20 Days)
- 4M
- –
- Average Volume (90 Days)
- 2M
- –
- Relative Volume
- 0.69
- 0.70
- Relative Strength Index (14)
- 26.8
- 43.4
- Volatility (1 Year)
- 67.2%
- 80.1%
- Beta (5 Years)
- 1.46
- 1.07
MarginsIndustry
- EBITDA Margin
- 42.5%
- -27.7%
- FCF Margin
- 52.7%
- -9.56%
Returns on capitalIndustry
- Return on Equity (ROE)
- 44.0%
- -49.9%
- Return on Assets (ROA)
- 34.3%
- -40.6%
- Return on Capital Employed (ROCE)
- 27.2%
- -37.9%
Financial positionIndustry
- Current Ratio
- 8.44
- 3.30
- Quick Ratio
- 8.57
- 2.39
GrowthIndustry
- Revenue Growth (YoY)
- 738.8%
- 6.82%
- Revenue Growth (3Y CAGR)
- 29.5%
- 2.25%
- Revenue Growth (5Y CAGR)
- 36.3%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 0.82
- 0.40
- Revenue Per Employee
- $2.21M
- $429.29K
- Profits Per Employee
- $930.21K
- -$689.41K
- Employee Count
- 317
- 74
- WACC
- 12.4%
- 10.2%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $1.10B
- $17.76M
- Net Cash Per Share
- $10.07
- $0.80
- Equity (Book Value)
- $968.31M
- $53.89M
- Book Value Per Share
- $8.86
- $1.50
- Tangible Book Value
- $968.31M
- $27.13M
- Working Capital
- $972.95M
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$9.50M
- -$1.00M
- FCF Per Share
- $3.38
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- 17.4%
- -21.8%
- FCF Yield
- 21.9%
- -9.44%
- Dividend Yield
- 0.00%
- 1.88%
- Buyback Yield
- -1.06%
- -0.76%
- Shareholder Yield
- -1.06%
- 0.00%
- Dividend Per Share
- $0.00
- $0.83
- Years of Dividend Growth
- 0
- 0
Taxes and interestIndustry
- Income Tax
- $13.34M
- $73.00K
Scores and fair valueIndustry
- Graham Number
- $21.46
- $19.34
- Graham Upside
- 38.7%
- -46.6%
- Altman Z-Score
- 6.10
- 0.23
- Piotroski F-Score
- 3
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | NRIX | S&P 500 | Difference | NRIX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -30.0% | -3.0% | −27.0 pts | ||
| 3 months | -43.1% | -2.8% | −40.3 pts | ||
| Year to date | -18.4% | +11.5% | −29.9 pts | ||
| 1 year | +24.5% | +13.5% | +11.1 pts | ||
| 3 years | +194.3% | +77.7% | +116.6 pts | +43.3% | +21.1% |
| 5 years | -54.6% | +72.6% | −127.2 pts | -14.6% | +11.5% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
19M NRIX shares were sold short on Oct 30, 2026, down 8.1% from the previous report, or 17.90% of the shares available to trade. At recent volumes it would take 7.2 days to buy them back. Over the last 20 sessions, 31.4% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 18,936,583 | -8.1% | 2,639,810 | 7.2 |
| Oct 15, 2026 | 20,607,897 | +16.7% | 2,235,864 | 9.2 |
| Sep 30, 2026 | 17,657,588 | -1.8% | 1,776,243 | 9.9 |
| Sep 15, 2026 | 17,976,804 | +0.1% | 1,279,919 | 14.1 |
| Aug 31, 2026 | 17,950,461 | -0.2% | 1,126,118 | 15.9 |
| Aug 14, 2026 | 17,984,342 | -2.0% | 993,103 | 18.1 |
| Jul 31, 2026 | 18,351,438 | +2.1% | 1,019,972 | 18.0 |
| Jul 15, 2026 | 17,979,165 | +1.0% | 1,296,203 | 13.9 |
| Jun 30, 2026 | 17,798,300 | -11.1% | 3,279,006 | 5.4 |
| Jun 15, 2026 | 20,024,913 | +3.6% | 4,050,135 | 4.9 |
| May 29, 2026 | 19,321,862 | +3.7% | 1,298,393 | 14.9 |
| May 15, 2026 | 18,633,310 | -3.0% | 838,931 | 22.2 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?